Thrombotic and Bleeding Outcomes Following Perioperative Interruption of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation - a Comparative Analysis

被引：0
|
作者：
Shaw, Joseph R. [1 ]
Zhang, Tinghua [2 ]
Le Gal, Gregoire [3 ]
Douketis, James [4 ]
Carrier, Marc [2 ,5 ]
机构：
[1] Univ Ottawa, Ottawa, ON, Canada
[2] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[3] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[4] McMaster Univ, Div Hematol & Thromboembolism, Dept Med, Hamilton, ON, Canada
[5] Ottawa Hosp, Ottawa Blood Dis Ctr, Ottawa, ON, Canada
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111698
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1234
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Thrombotic and Bleeding Outcomes Following Perioperative Interruption of DOACs and VKAs in Patients with Non-Valvular Atrial Fibrillation - A Comparative Analysis
    Shaw, Joseph
    Zhang, Tinghua
    Le Gal, Gregoire
    Douketis, James
    Carrier, Marc
    THROMBOSIS RESEARCH, 2018, 170 : 6 - 6
  • [2] Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
    Shaw, Joseph R.
    Zhang, Tinghua
    Le Gal, Gregoire
    Douketis, James
    Carrier, Marc
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (01) : 131 - 140
  • [3] Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation
    Saliba, Layla
    Mondoly, Pierre
    Duparc, Alexandre
    Bura-Riviere, Alessandra
    Maury, Philippe
    Calmels, Violaine
    Sallerin, Brigitte
    Pathak, Atul
    Montastruc, Jean-Louis
    Bagheri, Haleh
    THERAPIE, 2015, 70 (06): : 485 - 492
  • [4] Risk of fracture in patients with non-valvular atrial fibrillation initiating direct oral anticoagulants vs. vitamin K antagonists
    He, Na
    Dell'Aniello, Sophie
    Zhai, Suodi
    Suissa, Samy
    Renoux, Christel
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 389 - 397
  • [5] Non-valvular Atrial Fibrillation in CKD: Role of Vitamin K Antagonists and Direct Oral Anticoagulants. A Narrative Review
    Cases, Aleix
    Gomez, Pablo
    Jesus Broseta, Jose
    Perez Bernat, Elisa
    Arjona Barrionuevo, Juan de Dios
    Maria Portoles, Jose
    Luis Gorriz, Jose
    FRONTIERS IN MEDICINE, 2021, 8
  • [6] Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
    Cunha, Pedro Silva
    Monteiro, Andre Viveiros
    Cruz, Madalena Coutinho
    Malveiro, Paula
    Reis, Joao Pedro
    Portugal, Guilherme
    Dias, Ana
    Ferreira, Rui Cruz
    Oliveira, Mario Martins
    GERIATRICS, 2022, 7 (01)
  • [7] Comparative Outcomes of Direct Oral Anticoagulants versus Warfarin in Morbidly Obese Patients With Non-valvular Atrial Fibrillation
    Barakat, Amr F.
    Jain, Sandeep
    Masri, Ahmad
    Senussi, Mourad
    Wang, Yisi
    Bhonsale, Aditya
    Saba, Samir
    Mulukutla, Suresh R.
    CIRCULATION, 2019, 140
  • [8] Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
    Yasaka, Masahiro
    Lip, Gregory Y. H.
    CIRCULATION JOURNAL, 2014, 78 (10) : 2367 - 2372
  • [9] Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease
    Shaw, J.
    de Wit, C.
    Le Gal, G.
    Carrier, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (05) : 925 - 930
  • [10] Anticoagulation treatment safety with vitamin K antagonists and novel oral anticoagulants within the registry of patients with non-valvular atrial fibrillation
    Sokolova, A. A.
    Anikina, O. S.
    Zhilenko, A. V.
    Belousov, S. R.
    Napalkov, D. A.
    Sulimov, V. A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1113 - 1113
12345